Drawing for PHI

USPTO serial 88380126

PHI

Reviewed by CopyMark Law Group

Reg. 5884824Status 702Registered
Filing date
Status date
Registration date
Oct 15, 2019
Examiner
SAUNDERS, ANDREA DAWN
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with PHI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica G. McDonad

Jessica G. McDonad Schwegman Lundberg & Woessner P.A.P.O. Box 2938Minneapolis, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
042Laboratory analysis in the field of medicine, namely, analysis of chemical markers related to prostate for use in field of oncology and or urology; [ testing of chemicals; ] Providing medical testing services and information in the field of cancer research and disease classification; Analysis [ and development ] of tests in the field of cancer research and disease classification [ ; Scientific research ]ACTIVEJun 14, 2012
044Medical information; Providing healthcare information; Providing medical information to medical professionals in the form of biomedical data in the field of oncology and/or urology; Providing personalized healthcare and medical information in the form of biomedical data in the field of oncology and/or urology; Medical testing for diagnostic or treatment purposes; Medical diagnostic testing [ , monitoring, ] and reporting services; Medical testing of [ urine, ] blood [ , hair follicles or breath ]ACTIVEJun 14, 2012

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 17, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 17, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 17, 2025EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Sep 3, 2025PUM2OFFICE ACTION ISSUED POU2—
Jul 14, 2025EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jun 2, 2025PUM1OFFICE ACTION ISSUED POU1—
Jun 2, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 28, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Oct 15, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 15, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 26, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 26, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 30, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 30, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 10, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 20, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 20, 2019DOCKASSIGNED TO EXAMINER—
Apr 27, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 13, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance